Transcriptome-wide analysis of natural antisense transcripts shows their potential role in breast cancer

• Published in: Scientific reports 2017-12, Vol.7 (1), p.17452-12, Article 17452
• Main Authors: Wenric, Stephane, ElGuendi, Sonia, Caberg, Jean-Hubert, Bezzaou, Warda, Fasquelle, Corinne, Charloteaux, Benoit, Karim, Latifa, Hennuy, Benoit, Frères, Pierre, Collignon, Joëlle, Boukerroucha, Meriem, Schroeder, Hélène, Olivier, Fabrice, Jossa, Véronique, Jerusalem, Guy, Josse, Claire, Bours, Vincent
• Format: Article
• Language: English
• Subjects: 45/22; 45/23; 45/61; 45/91; 631/114/2163; 631/208/200; 631/208/212/2019; 631/208/69; 692/4028/67/69; Adult; Aged; Aged, 80 and over; Antisense RNA; Biomarkers, Tumor - genetics; Biomarkers, Tumor - metabolism; Breast cancer; Breast Neoplasms - genetics; Breast Neoplasms - metabolism; Breast Neoplasms - mortality; Correlation analysis; Data processing; Estrogen receptors; Estrogens; Female; Gene expression; Gene Expression Profiling - methods; Genetics & genetic processes; Genomes; Génétique & processus génétiques; Humanities and Social Sciences; Humans; Life sciences; Middle Aged; multidisciplinary; Non-coding RNA; Proteins; Receptor mechanisms; Receptor, ErbB-2 - genetics; Receptor, ErbB-2 - metabolism; Receptors, Estrogen - genetics; Receptors, Estrogen - metabolism; Retrospective Studies; Ribonucleic acid; RNA; RNA, Antisense - metabolism; RNA, Untranslated - metabolism; Science; Science (multidisciplinary); Sciences du vivant; Sequence Analysis, RNA; Survival Analysis; Transcription; Transcriptome
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-017-17811-2

Non-coding RNAs (ncRNA) represent 1/5 of the mammalian transcript number, and 90% of the genome length is transcribed. Many ncRNAs play a role in cancer. Among them, non-coding natural antisense transcripts (ncNAT) are RNA sequences that are complementary and overlapping to those of either protein-coding (PCT) or non-coding transcripts. Several ncNATs were described as regulating protein coding gene expression on the same loci, and they are expected to act more frequently in cis compared to other ncRNAs that commonly function in trans . In this work, 22 breast cancers expressing estrogen receptors and their paired adjacent non-malignant tissues were analyzed by strand-specific RNA sequencing. To highlight ncNATs potentially playing a role in protein coding gene regulations that occur in breast cancer, three different data analysis methods were used: differential expression analysis of ncNATs between tumor and non-malignant tissues, differential correlation analysis of paired ncNAT/PCT between tumor and non-malignant tissues, and ncNAT/PCT read count ratio variation between tumor and non-malignant tissues. Each of these methods yielded lists of ncNAT/PCT pairs that were enriched in survival-associated genes. This work highlights ncNAT lists that display potential to affect the expression of protein-coding genes involved in breast cancer pathology.